White House Nears Deal to Lower Obesity Drug Prices for Medicare Coverage

obesity-drugs-2ndld-writethru-JETEWNCL33INZYI373E7PKGFQA
The White House is expected to announce a deal this week with Eli Lilly and Novo Nordisk that would lower the price of their popular obesity drugs to $149 per month in some cases, according to four people familiar with the agreement who spoke on the condition of anonymity to preview the deal.

New contents